{"gene":"GPR151","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2021,"finding":"GPR151 physically couples with P2X3 ion channels in nociceptive DRG neurons and promotes P2X3 functional activity; conditional knockout of Gpr151 suppressed P2X3-mediated calcium elevation, while overexpression of Gpr151 enhanced P2X3-mediated calcium elevation and neuronal excitability, placing GPR151 upstream of P2X3 in neuropathic pain signaling.","method":"Co-immunoprecipitation (coupling), calcium imaging, conditional knockout and overexpression in DRG neurons, behavioral assays","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal functional coupling demonstrated by both loss-of-function (KO) and gain-of-function (overexpression) with defined calcium signaling readout, replicated across behavioral and cellular levels in same study","pmids":["34244727"],"is_preprint":false},{"year":2021,"finding":"GPR151 in DRG neurons is required for nerve injury-induced upregulation of CSF1, which drives microglial activation in the spinal cord; knockdown of P2X3 reversed CSF1 upregulation and spinal microglial activation, placing GPR151 → P2X3 → CSF1 → microglial activation in a defined pathway.","method":"Conditional knockout, knockdown, immunostaining for microglial activation markers, CSF1 protein/mRNA quantification","journal":"Brain : a journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, two orthogonal methods (KO and knockdown), clear pathway placement but no in vitro reconstitution","pmids":["34244727"],"is_preprint":false},{"year":2021,"finding":"GPR151 couples to Gαi protein (but not Gαq, Gα12, or Gα13) and activates ERK through Gβγ in trigeminal ganglion neurons; Gpr151-/- mice failed to show pIONT-induced ERK activation, and ERK inhibition reduced neuroinflammatory chemokine upregulation (CCL5, CCL7, CXCL9, CXCL10).","method":"Co-immunoprecipitation for G-protein selectivity, ERK phosphorylation assays in WT vs Gpr151-/- mice, gene microarray, pharmacological inhibition (PD98059)","journal":"Pain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, reciprocal KO + Co-IP for G-protein coupling specificity, multiple downstream readouts","pmids":["33239523"],"is_preprint":false},{"year":2019,"finding":"GPR151 is activated under acidic conditions (pH ~5.8), functioning as a proton-sensing GPCR; this was demonstrated by increased [35S]GTPγS binding by GPR151-Giα fusion proteins and reporter gene assays in CHO cells expressing recombinant GPR151, confirming Gi coupling.","method":"[35S]GTPγS binding assay with GPR151-Giα fusion protein, reporter gene assay in CHO cells","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assay plus cell-based reporter assay, single lab, two orthogonal methods","pmids":["31119277"],"is_preprint":false},{"year":2016,"finding":"Galanin (at 100 nM–10 μM) did not induce calcium signaling responses in ND7/23 cells transfected with GPR151, indicating galanin is not an endogenous ligand for GPR151.","method":"Calcium signaling assay in transfected ND7/23 cells","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay with negative result, single lab; galanin-as-ligand hypothesis rejected","pmids":["27913310"],"is_preprint":false},{"year":2022,"finding":"GPR151 loss-of-function (Gpr151-/-) mice show reduced social preference compared to wild-type controls, establishing a role for habenular GPR151 in promoting social reward behavior, likely by dampening aversive habenular activity.","method":"Gpr151-/- mouse behavioral testing (social preference test)","journal":"Scientific reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single behavioral assay in KO mice, single lab, no molecular mechanism defined","pmids":["36424418"],"is_preprint":false},{"year":2026,"finding":"Cryo-EM/structural determination of GPR151 using the NELiS platform revealed unconventional activation-resistant features in canonical motifs and an autoinhibitory N-terminal region occupying the orthosteric pocket; functional studies confirmed the N-terminus is critical for receptor maturation and trafficking.","method":"Structure determination (cryo-EM implied via stabilizing mutations + nanobody), thermostability assays, functional receptor trafficking/maturation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural determination combined with functional validation of N-terminal autoinhibitory role and trafficking, single study but multiple orthogonal methods","pmids":["42085164"],"is_preprint":false},{"year":2026,"finding":"Novel psoralen-ring ligands (GUM3 as agonist, GUM4 as partial agonist) for GPR151 were identified; both induced GPR151 internalization and activated reporter gene expression in CHO cells expressing human GPR151. Co-administration with morphine showed agonist GUM3 enhanced and partial agonist GUM4 attenuated morphine analgesia, demonstrating GPR151 modulates opioid signaling.","method":"[35S]GTPγS binding assay, receptor internalization assay, reporter gene assay in CHO cells, in vivo thermal hyperalgesia and morphine analgesia assays in rats","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical and cell-based assays plus in vivo pharmacology, single lab, multiple methods","pmids":["42104714"],"is_preprint":false},{"year":2022,"finding":"In vitro confirmation that three homozygous loss-of-function GPR151 variants (Arg95Ter, Tyr99Ter, Phe175LeufsTer7) are non-functional (loss-of-function confirmed), while Gpr151-/- mice show no difference in body weight on normal chow but higher body weight on high-fat diet versus Gpr151+/+ mice.","method":"In vitro loss-of-function assay for human variants, mouse KO phenotyping under normal chow and high-fat diet","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vitro validation of variant loss-of-function combined with KO mouse metabolic phenotyping, single lab","pmids":["35381001"],"is_preprint":false},{"year":2014,"finding":"GPR151 protein is specifically expressed in habenular neurons and their efferent axonal projections to the interpeduncular nucleus, rostromedial tegmental area, raphe nuclei, and dorsal tegmental nucleus; GPR151-expressing axons overlap with cholinergic, substance P-ergic, and glutamatergic markers, as determined by immunohistochemistry and confocal quantitative colocalization analysis in rat, mouse, and zebrafish.","method":"Immunohistochemistry, confocal microscopy, quantitative colocalization analysis across rat, mouse, zebrafish","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Strong — conserved localization independently validated across three species with quantitative colocalization","pmids":["25116430"],"is_preprint":false}],"current_model":"GPR151 is an orphan Gi-coupled GPCR expressed in habenular neurons and nociceptive DRG/trigeminal ganglion neurons that is activated by acidic pH, physically couples with P2X3 ion channels to enhance their activity in pain signaling, signals through Gβγ/ERK to drive neuroinflammatory chemokine expression, possesses an autoinhibitory N-terminal region occupying the orthosteric pocket that governs receptor maturation and trafficking, and modulates both neuropathic pain and social reward behavior in mice."},"narrative":{"mechanistic_narrative":"GPR151 is a Gi-coupled G protein-coupled receptor with a restricted neuronal expression pattern that functions in pain signaling and habenular reward circuitry [PMID:34244727, PMID:25116430]. It is selectively expressed in habenular neurons and their efferent axonal projections to the interpeduncular nucleus, raphe nuclei, and tegmental targets, where its axons overlap with cholinergic, substance P-ergic, and glutamatergic markers [PMID:25116430]. The receptor couples specifically to Gαi (and not Gαq, Gα12, or Gα13) and is activated under acidic conditions (~pH 5.8), acting as a proton-sensing receptor [PMID:33239523, PMID:31119277]. In nociceptive DRG neurons, GPR151 physically couples to P2X3 ion channels and enhances P2X3-mediated calcium influx and excitability, placing it upstream of a P2X3 → CSF1 → spinal microglial activation cascade in neuropathic pain [PMID:34244727]. In trigeminal ganglion neurons it signals through Gβγ to activate ERK, driving upregulation of neuroinflammatory chemokines (CCL5, CCL7, CXCL9, CXCL10) [PMID:33239523]. Structural determination revealed activation-resistant features in canonical motifs and an autoinhibitory N-terminal region occupying the orthosteric pocket that governs receptor maturation and trafficking [PMID:42085164]. Synthetic psoralen-ring agonists and partial agonists drive GPR151 internalization and signaling and bidirectionally modulate morphine analgesia, while galanin was excluded as an endogenous ligand [PMID:27913310, PMID:42104714]. Behaviorally, loss of GPR151 reduces social preference and alters diet-dependent body weight [PMID:36424418, PMID:35381001].","teleology":[{"year":2014,"claim":"Establishing where GPR151 acts: defining its restricted expression resolved the anatomical substrate for the receptor's function before any ligand or signaling mechanism was known.","evidence":"Immunohistochemistry and quantitative confocal colocalization across rat, mouse, and zebrafish","pmids":["25116430"],"confidence":"Medium","gaps":["Does not establish signaling mechanism or ligand","Functional consequence of habenular expression not tested"]},{"year":2016,"claim":"Testing a candidate endogenous ligand: galanin was directly excluded, narrowing the deorphanization search.","evidence":"Calcium signaling assay in GPR151-transfected ND7/23 cells (negative result)","pmids":["27913310"],"confidence":"Medium","gaps":["Negative result only; does not identify the true ligand","Single cell system"]},{"year":2019,"claim":"Defining a stimulus and transducer: GPR151 was shown to be activated by acidic pH and to couple to Gi, providing the first biochemical signaling readout.","evidence":"[35S]GTPγS binding with GPR151-Giα fusion and reporter gene assay in CHO cells","pmids":["31119277"],"confidence":"Medium","gaps":["Whether protons are the physiological activator in vivo unresolved","No structural basis for pH sensing"]},{"year":2021,"claim":"Connecting the receptor to a pain effector: GPR151 was placed upstream of P2X3 channels via physical coupling and bidirectional functional control of P2X3 activity, defining a neuropathic pain mechanism.","evidence":"Co-IP, calcium imaging, conditional KO and overexpression in DRG neurons, behavioral assays","pmids":["34244727"],"confidence":"High","gaps":["Molecular interface of GPR151-P2X3 coupling not resolved","Whether coupling requires G-protein signaling unclear"]},{"year":2021,"claim":"Extending the pathway to neuroinflammation: GPR151 → P2X3 was linked to CSF1 upregulation and spinal microglial activation, and a parallel Gβγ/ERK arm was shown to drive chemokine expression.","evidence":"Conditional KO and knockdown with microglial/chemokine readouts; Co-IP for Gαi selectivity and ERK phosphorylation in WT vs Gpr151-/- mice with PD98059 inhibition","pmids":["34244727","33239523"],"confidence":"Medium","gaps":["No in vitro reconstitution of the pathway","Single lab for each arm","Relationship between P2X3 arm and Gβγ/ERK arm not integrated"]},{"year":2022,"claim":"Probing physiological roles beyond pain: KO mice revealed contributions of GPR151 to social reward behavior and diet-dependent metabolism, and human loss-of-function variants were confirmed non-functional.","evidence":"Gpr151-/- mouse behavior, metabolic phenotyping, and in vitro variant loss-of-function assays","pmids":["36424418","35381001"],"confidence":"Low","gaps":["Social preference finding rests on a single behavioral assay with no molecular mechanism","Metabolic mechanism not defined","Link between habenular circuitry and behavior not mechanistically established"]},{"year":2026,"claim":"Resolving receptor architecture and pharmacology: structure revealed an autoinhibitory N-terminus controlling maturation/trafficking, and synthetic ligands established GPR151 as a druggable modulator of opioid analgesia.","evidence":"Structure determination with stabilizing mutations/nanobody plus trafficking assays; psoralen-ring agonist/partial agonist characterization with morphine co-administration in rats","pmids":["42085164","42104714"],"confidence":"High","gaps":["Endogenous ligand still unidentified","Mechanism by which N-terminal autoinhibition is relieved unknown","How synthetic ligands intersect opioid signaling pathway not resolved"]},{"year":null,"claim":"The endogenous ligand of GPR151 and how its autoinhibited, activation-resistant architecture is physiologically engaged remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No validated endogenous agonist identified","Physiological trigger for N-terminal autoinhibition relief unknown","Mechanistic link between habenular signaling and behavioral phenotypes incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,3]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,9]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[9]}],"complexes":[],"partners":["P2X3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8TDV0","full_name":"G-protein coupled receptor 151","aliases":["G-protein coupled receptor PGR7","GPCR-2037","Galanin receptor 4","Galanin-receptor-like protein","GalRL"],"length_aa":419,"mass_kda":46.6,"function":"Proton-sensing G-protein coupled receptor","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q8TDV0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GPR151","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GPR151","total_profiled":1310},"omim":[{"mim_id":"618487","title":"G PROTEIN-COUPLED RECEPTOR 151; GPR151","url":"https://www.omim.org/entry/618487"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GPR151"},"hgnc":{"alias_symbol":["PGR7","GALR4"],"prev_symbol":[]},"alphafold":{"accession":"Q8TDV0","domains":[{"cath_id":"1.20.1070.10","chopping":"17-320","consensus_level":"high","plddt":90.1876,"start":17,"end":320}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDV0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDV0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDV0-F1-predicted_aligned_error_v6.png","plddt_mean":78.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GPR151","jax_strain_url":"https://www.jax.org/strain/search?query=GPR151"},"sequence":{"accession":"Q8TDV0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TDV0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TDV0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDV0"}},"corpus_meta":[{"pmid":"34244727","id":"PMC_34244727","title":"GPR151 in nociceptors modulates neuropathic pain via regulating P2X3 function and microglial activation.","date":"2021","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34244727","citation_count":77,"is_preprint":false},{"pmid":"25116430","id":"PMC_25116430","title":"Conserved expression of the GPR151 receptor in habenular axonal projections of vertebrates.","date":"2014","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25116430","citation_count":44,"is_preprint":false},{"pmid":"33239523","id":"PMC_33239523","title":"G protein-coupled receptor GPR151 is involved in trigeminal neuropathic pain through the induction of Gβγ/extracellular signal-regulated kinase-mediated neuroinflammation in the trigeminal ganglion.","date":"2021","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/33239523","citation_count":32,"is_preprint":false},{"pmid":"31119277","id":"PMC_31119277","title":"GPR31 and GPR151 are activated under acidic conditions.","date":"2019","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31119277","citation_count":26,"is_preprint":false},{"pmid":"28657115","id":"PMC_28657115","title":"Monosynaptic retrograde tracing of neurons expressing the G-protein coupled receptor Gpr151 in the mouse brain.","date":"2017","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28657115","citation_count":22,"is_preprint":false},{"pmid":"27913310","id":"PMC_27913310","title":"Targeted disruption of the orphan receptor Gpr151 does not alter pain-related behaviour despite a strong induction in dorsal root ganglion expression in a model of neuropathic pain.","date":"2016","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/27913310","citation_count":22,"is_preprint":false},{"pmid":"36424418","id":"PMC_36424418","title":"The mu opioid receptor and the orphan receptor GPR151 contribute to social reward in the habenula.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36424418","citation_count":15,"is_preprint":false},{"pmid":"35011589","id":"PMC_35011589","title":"Expression of Proton-Sensitive GPR31, GPR151, TASK1 and TASK3 in Common Skin Tumors.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35011589","citation_count":7,"is_preprint":false},{"pmid":"37296398","id":"PMC_37296398","title":"Deep learning-based classification model for GPR151 activator activity prediction.","date":"2023","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/37296398","citation_count":4,"is_preprint":false},{"pmid":"40295925","id":"PMC_40295925","title":"The Orphan Receptor GPR151: Discovery, Expression, and Emerging Biological Significance.","date":"2025","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/40295925","citation_count":3,"is_preprint":false},{"pmid":"22842078","id":"PMC_22842078","title":"Characterization of the theta replication plasmid pGR7 from Acetobacter aceti CCM 3610.","date":"2012","source":"Research in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/22842078","citation_count":3,"is_preprint":false},{"pmid":"35381001","id":"PMC_35381001","title":"Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass index.","date":"2022","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35381001","citation_count":3,"is_preprint":false},{"pmid":"42085164","id":"PMC_42085164","title":"Decoding the structure of GPR151 via NELiS.","date":"2026","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/42085164","citation_count":0,"is_preprint":false},{"pmid":"42104714","id":"PMC_42104714","title":"Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action.","date":"2026","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/42104714","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8632,"output_tokens":2443,"usd":0.03127,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9659,"output_tokens":2658,"usd":0.057372,"stage2_stop_reason":"end_turn"},"total_usd":0.088642,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR151 physically couples with P2X3 ion channels in nociceptive DRG neurons and promotes P2X3 functional activity; conditional knockout of Gpr151 suppressed P2X3-mediated calcium elevation, while overexpression of Gpr151 enhanced P2X3-mediated calcium elevation and neuronal excitability, placing GPR151 upstream of P2X3 in neuropathic pain signaling.\",\n      \"method\": \"Co-immunoprecipitation (coupling), calcium imaging, conditional knockout and overexpression in DRG neurons, behavioral assays\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal functional coupling demonstrated by both loss-of-function (KO) and gain-of-function (overexpression) with defined calcium signaling readout, replicated across behavioral and cellular levels in same study\",\n      \"pmids\": [\"34244727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR151 in DRG neurons is required for nerve injury-induced upregulation of CSF1, which drives microglial activation in the spinal cord; knockdown of P2X3 reversed CSF1 upregulation and spinal microglial activation, placing GPR151 → P2X3 → CSF1 → microglial activation in a defined pathway.\",\n      \"method\": \"Conditional knockout, knockdown, immunostaining for microglial activation markers, CSF1 protein/mRNA quantification\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, two orthogonal methods (KO and knockdown), clear pathway placement but no in vitro reconstitution\",\n      \"pmids\": [\"34244727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR151 couples to Gαi protein (but not Gαq, Gα12, or Gα13) and activates ERK through Gβγ in trigeminal ganglion neurons; Gpr151-/- mice failed to show pIONT-induced ERK activation, and ERK inhibition reduced neuroinflammatory chemokine upregulation (CCL5, CCL7, CXCL9, CXCL10).\",\n      \"method\": \"Co-immunoprecipitation for G-protein selectivity, ERK phosphorylation assays in WT vs Gpr151-/- mice, gene microarray, pharmacological inhibition (PD98059)\",\n      \"journal\": \"Pain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, reciprocal KO + Co-IP for G-protein coupling specificity, multiple downstream readouts\",\n      \"pmids\": [\"33239523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GPR151 is activated under acidic conditions (pH ~5.8), functioning as a proton-sensing GPCR; this was demonstrated by increased [35S]GTPγS binding by GPR151-Giα fusion proteins and reporter gene assays in CHO cells expressing recombinant GPR151, confirming Gi coupling.\",\n      \"method\": \"[35S]GTPγS binding assay with GPR151-Giα fusion protein, reporter gene assay in CHO cells\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assay plus cell-based reporter assay, single lab, two orthogonal methods\",\n      \"pmids\": [\"31119277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Galanin (at 100 nM–10 μM) did not induce calcium signaling responses in ND7/23 cells transfected with GPR151, indicating galanin is not an endogenous ligand for GPR151.\",\n      \"method\": \"Calcium signaling assay in transfected ND7/23 cells\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay with negative result, single lab; galanin-as-ligand hypothesis rejected\",\n      \"pmids\": [\"27913310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GPR151 loss-of-function (Gpr151-/-) mice show reduced social preference compared to wild-type controls, establishing a role for habenular GPR151 in promoting social reward behavior, likely by dampening aversive habenular activity.\",\n      \"method\": \"Gpr151-/- mouse behavioral testing (social preference test)\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single behavioral assay in KO mice, single lab, no molecular mechanism defined\",\n      \"pmids\": [\"36424418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Cryo-EM/structural determination of GPR151 using the NELiS platform revealed unconventional activation-resistant features in canonical motifs and an autoinhibitory N-terminal region occupying the orthosteric pocket; functional studies confirmed the N-terminus is critical for receptor maturation and trafficking.\",\n      \"method\": \"Structure determination (cryo-EM implied via stabilizing mutations + nanobody), thermostability assays, functional receptor trafficking/maturation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural determination combined with functional validation of N-terminal autoinhibitory role and trafficking, single study but multiple orthogonal methods\",\n      \"pmids\": [\"42085164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Novel psoralen-ring ligands (GUM3 as agonist, GUM4 as partial agonist) for GPR151 were identified; both induced GPR151 internalization and activated reporter gene expression in CHO cells expressing human GPR151. Co-administration with morphine showed agonist GUM3 enhanced and partial agonist GUM4 attenuated morphine analgesia, demonstrating GPR151 modulates opioid signaling.\",\n      \"method\": \"[35S]GTPγS binding assay, receptor internalization assay, reporter gene assay in CHO cells, in vivo thermal hyperalgesia and morphine analgesia assays in rats\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical and cell-based assays plus in vivo pharmacology, single lab, multiple methods\",\n      \"pmids\": [\"42104714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In vitro confirmation that three homozygous loss-of-function GPR151 variants (Arg95Ter, Tyr99Ter, Phe175LeufsTer7) are non-functional (loss-of-function confirmed), while Gpr151-/- mice show no difference in body weight on normal chow but higher body weight on high-fat diet versus Gpr151+/+ mice.\",\n      \"method\": \"In vitro loss-of-function assay for human variants, mouse KO phenotyping under normal chow and high-fat diet\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vitro validation of variant loss-of-function combined with KO mouse metabolic phenotyping, single lab\",\n      \"pmids\": [\"35381001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GPR151 protein is specifically expressed in habenular neurons and their efferent axonal projections to the interpeduncular nucleus, rostromedial tegmental area, raphe nuclei, and dorsal tegmental nucleus; GPR151-expressing axons overlap with cholinergic, substance P-ergic, and glutamatergic markers, as determined by immunohistochemistry and confocal quantitative colocalization analysis in rat, mouse, and zebrafish.\",\n      \"method\": \"Immunohistochemistry, confocal microscopy, quantitative colocalization analysis across rat, mouse, zebrafish\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conserved localization independently validated across three species with quantitative colocalization\",\n      \"pmids\": [\"25116430\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GPR151 is an orphan Gi-coupled GPCR expressed in habenular neurons and nociceptive DRG/trigeminal ganglion neurons that is activated by acidic pH, physically couples with P2X3 ion channels to enhance their activity in pain signaling, signals through Gβγ/ERK to drive neuroinflammatory chemokine expression, possesses an autoinhibitory N-terminal region occupying the orthosteric pocket that governs receptor maturation and trafficking, and modulates both neuropathic pain and social reward behavior in mice.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GPR151 is a Gi-coupled G protein-coupled receptor with a restricted neuronal expression pattern that functions in pain signaling and habenular reward circuitry [#0, #9]. It is selectively expressed in habenular neurons and their efferent axonal projections to the interpeduncular nucleus, raphe nuclei, and tegmental targets, where its axons overlap with cholinergic, substance P-ergic, and glutamatergic markers [#9]. The receptor couples specifically to Gαi (and not Gαq, Gα12, or Gα13) and is activated under acidic conditions (~pH 5.8), acting as a proton-sensing receptor [#2, #3]. In nociceptive DRG neurons, GPR151 physically couples to P2X3 ion channels and enhances P2X3-mediated calcium influx and excitability, placing it upstream of a P2X3 → CSF1 → spinal microglial activation cascade in neuropathic pain [#0, #1]. In trigeminal ganglion neurons it signals through Gβγ to activate ERK, driving upregulation of neuroinflammatory chemokines (CCL5, CCL7, CXCL9, CXCL10) [#2]. Structural determination revealed activation-resistant features in canonical motifs and an autoinhibitory N-terminal region occupying the orthosteric pocket that governs receptor maturation and trafficking [#6]. Synthetic psoralen-ring agonists and partial agonists drive GPR151 internalization and signaling and bidirectionally modulate morphine analgesia, while galanin was excluded as an endogenous ligand [#4, #7]. Behaviorally, loss of GPR151 reduces social preference and alters diet-dependent body weight [#5, #8].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Establishing where GPR151 acts: defining its restricted expression resolved the anatomical substrate for the receptor's function before any ligand or signaling mechanism was known.\",\n      \"evidence\": \"Immunohistochemistry and quantitative confocal colocalization across rat, mouse, and zebrafish\",\n      \"pmids\": [\"25116430\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not establish signaling mechanism or ligand\", \"Functional consequence of habenular expression not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Testing a candidate endogenous ligand: galanin was directly excluded, narrowing the deorphanization search.\",\n      \"evidence\": \"Calcium signaling assay in GPR151-transfected ND7/23 cells (negative result)\",\n      \"pmids\": [\"27913310\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative result only; does not identify the true ligand\", \"Single cell system\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defining a stimulus and transducer: GPR151 was shown to be activated by acidic pH and to couple to Gi, providing the first biochemical signaling readout.\",\n      \"evidence\": \"[35S]GTPγS binding with GPR151-Giα fusion and reporter gene assay in CHO cells\",\n      \"pmids\": [\"31119277\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether protons are the physiological activator in vivo unresolved\", \"No structural basis for pH sensing\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connecting the receptor to a pain effector: GPR151 was placed upstream of P2X3 channels via physical coupling and bidirectional functional control of P2X3 activity, defining a neuropathic pain mechanism.\",\n      \"evidence\": \"Co-IP, calcium imaging, conditional KO and overexpression in DRG neurons, behavioral assays\",\n      \"pmids\": [\"34244727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular interface of GPR151-P2X3 coupling not resolved\", \"Whether coupling requires G-protein signaling unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extending the pathway to neuroinflammation: GPR151 → P2X3 was linked to CSF1 upregulation and spinal microglial activation, and a parallel Gβγ/ERK arm was shown to drive chemokine expression.\",\n      \"evidence\": \"Conditional KO and knockdown with microglial/chemokine readouts; Co-IP for Gαi selectivity and ERK phosphorylation in WT vs Gpr151-/- mice with PD98059 inhibition\",\n      \"pmids\": [\"34244727\", \"33239523\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro reconstitution of the pathway\", \"Single lab for each arm\", \"Relationship between P2X3 arm and Gβγ/ERK arm not integrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Probing physiological roles beyond pain: KO mice revealed contributions of GPR151 to social reward behavior and diet-dependent metabolism, and human loss-of-function variants were confirmed non-functional.\",\n      \"evidence\": \"Gpr151-/- mouse behavior, metabolic phenotyping, and in vitro variant loss-of-function assays\",\n      \"pmids\": [\"36424418\", \"35381001\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Social preference finding rests on a single behavioral assay with no molecular mechanism\", \"Metabolic mechanism not defined\", \"Link between habenular circuitry and behavior not mechanistically established\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Resolving receptor architecture and pharmacology: structure revealed an autoinhibitory N-terminus controlling maturation/trafficking, and synthetic ligands established GPR151 as a druggable modulator of opioid analgesia.\",\n      \"evidence\": \"Structure determination with stabilizing mutations/nanobody plus trafficking assays; psoralen-ring agonist/partial agonist characterization with morphine co-administration in rats\",\n      \"pmids\": [\"42085164\", \"42104714\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous ligand still unidentified\", \"Mechanism by which N-terminal autoinhibition is relieved unknown\", \"How synthetic ligands intersect opioid signaling pathway not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The endogenous ligand of GPR151 and how its autoinhibited, activation-resistant architecture is physiologically engaged remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No validated endogenous agonist identified\", \"Physiological trigger for N-terminal autoinhibition relief unknown\", \"Mechanistic link between habenular signaling and behavioral phenotypes incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"P2X3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":8,"faith_total":8,"faith_pct":100.0}}